Home › Funds › Michelson Medical Research Foundation, Inc. › VB

Michelson Medical Research Foundation, Inc. position in VB

VANGUARD INDEX FDS

Michelson Medical Research Foundation, Inc. reported holding 11,010 shares of VB (VANGUARD INDEX FDS) in its Q3 2026 13F filing — a position valued at US$3.1M, representing 2.78% of its reported portfolio and ranking #13 among its reported holdings. Michelson Medical Research Foundation, Inc. has disclosed VB holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)11.01K sh
Reported value held$3.13M
Portfolio Weight2.78%
First reportedQ3 2023
Last changeHold
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Michelson Medical Research Foundation, Inc.'s VB position evolved

Michelson Medical Research Foundation, Inc. first disclosed a stake in VB in Q3 2023 at 18,910 shares (US$3.6M). The position peaked in Q3 2024 at 18,910 shares, worth US$4.5M. Across 13 filings, Michelson Medical Research Foundation, Inc. increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 11 time(s). The most recent filing (Q3 2026) shows 11,010 shares valued at US$3.1M. Notable position changes include a 42% trim in Q4 2024 (shares fell 8% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 18.91K $3.58M New
Q4 2023 18.91K $4.03M Hold
Q1 2024 18.91K $4.32M Hold
Q2 2024 18.91K $4.12M Hold
Q3 2024 18.91K $4.49M Hold
Q4 2024 11.01K $2.65M Reduce
Q1 2025 11.01K $2.44M Hold
Q2 2025 11.01K $2.61M Hold
Q3 2025 11.01K $2.80M Hold
Q4 2025 11.01K $2.84M Hold
Q1 2026 11.01K $2.88M Hold
Q2 2026 11.01K $3.34M Hold
Q3 2026 11.01K $3.13M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About VB and 13F data

VB (VANGUARD INDEX FDS) is a company whose sector is not yet classified in our data. 28 other funds we track also report a position in VB — the largest reported positions include Bank of America Corp (US$6.12B), Wells Fargo & Co (US$1.55B), UBS Group AG (US$1.18B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VB

All VB fund holders →

FAQ

How long has Michelson Medical Research Foundation, Inc. held VB?

Michelson Medical Research Foundation, Inc. has disclosed VB holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Michelson Medical Research Foundation, Inc.'s current position in VB?

As of Q3 2026, Michelson Medical Research Foundation, Inc. holds 11.01K shares of VB (VANGUARD INDEX FDS), valued at $3.13M, representing 2.78% of its reported portfolio and ranking #13.

Has Michelson Medical Research Foundation, Inc. been buying or selling VB?

In the latest 13F filing (Q3 2026), Michelson Medical Research Foundation, Inc. held unchanged its position in VB. The position peaked in Q3 2024 at 18.91K shares.

Which other funds hold VB?

Other major institutional holders of VB include Bank of America Corp, Wells Fargo & Co, UBS Group AG, among 28 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.